Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mayo Clinic Laboratories, |
RCV001508644 | SCV001714927 | uncertain significance | not provided | 2020-10-13 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002488310 | SCV002792450 | uncertain significance | Upshaw-Schulman syndrome | 2022-02-16 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002567994 | SCV003580246 | uncertain significance | Inborn genetic diseases | 2021-10-20 | criteria provided, single submitter | clinical testing | The c.3599C>A (p.T1200K) alteration is located in exon 26 (coding exon 26) of the ADAMTS13 gene. This alteration results from a C to A substitution at nucleotide position 3599, causing the threonine (T) at amino acid position 1200 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |